Eureka Therapeutics Stock

eurekatherapeutics.comBioTechFounded: 2006Funding to Date: $52.37MM

Eureka Therapeutics is a biotechnology company focused on breakthrough immunotherapies for the treatment of cancer.

Register for Details

For more details on financing and valuation for Eureka Therapeutics, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Eureka Therapeutics.

Register Today

Team

Management Team

Cheng Liu Ph.D
Founder, President, Chief Executive Officer and Board Member
Jingyi Xiang Ph.D
Head, Bioanalytics
Yiyang Xu Ph.D
Head, Phage display
Vivien Chan Ph.D
Head, Portfolio Management

Board Members

Bruce Ames
Cheng Liu Ph.D
Chih-Kai Cheng
Harbinger Venture Management
Hsing Kung Ph.D
Acorn Campus Ventures
Hsing-Jien Kung Ph.D
Michael Cannon
Peter Lee MD
Qiushi Fu
Wai-Yan Chau
Wei Zhou Ph.D

Other companies like Eureka Therapeutics in the BioTech sector

Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$1.3B
Sector
Last Round Est. Valuation
$3.1B
Sector
Last Round Est. Valuation
$5.81B
Sector
Last Round Est. Valuation
$1.2B
Sector
Last Round Est. Valuation
$1.6B
Sector
Last Round Est. Valuation
$1.61B